PFIZER HEALTHCARE
Public payment, procurement award, tender and lobbying-overlap records for this supplier name in the dail_tracker snapshot.
EUR 293,994,644
Safe-to-sum realised payments.
122
Payment rows.
EUR 0
Safe award values, not added to payments.
0
Lobbying/procurement co-occurrence rows.
Caveat: Award values, payment values and tender estimates are separate value grains and are not summed together. Supplier/lobbying co-occurrence is not evidence of influence.
Payments
| Authority | Period | Amount | Value kind | Evidence |
|---|---|---|---|---|
| Health Service Executive | 2025-Q3 | EUR 6,631,373 | payment_actual | source |
| Health Service Executive | 2025-Q3 | EUR 6,631,373 | payment_actual | source |
| Health Service Executive | 2025-Q3 | EUR 3,661,070 | payment_actual | source |
| Health Service Executive | 2025-Q3 | EUR 3,453,840 | payment_actual | source |
| Health Service Executive | 2025-Q3 | EUR 2,503,050 | payment_actual | source |
| Health Service Executive | 2025-Q1 | EUR 1,623,600 | payment_actual | source |
| Health Service Executive | 2025-Q3 | EUR 1,549,800 | payment_actual | source |
| Health Service Executive | 2025-Q1 | EUR 1,290,000 | payment_actual | source |
| Health Service Executive | 2025-Q1 | EUR 967,075 | payment_actual | source |
| Health Service Executive | 2025-Q1 | EUR 967,075 | payment_actual | source |
| Health Service Executive | 2025-Q1 | EUR 483,538 | payment_actual | source |
| Health Service Executive | 2025-Q3 | EUR 138,154 | payment_actual | source |
| Health Service Executive | 2024-Q1 | EUR 2,417,688 | payment_actual | source |
| Health Service Executive | 2024-Q2 | EUR 2,417,688 | payment_actual | source |
| Health Service Executive | 2024-Q1 | EUR 1,549,800 | payment_actual | source |
| Health Service Executive | 2024-Q4 | EUR 1,312,459 | payment_actual | source |
| Health Service Executive | 2024-Q2 | EUR 1,174,306 | payment_actual | source |
| Health Service Executive | 2024-Q4 | EUR 1,105,229 | payment_actual | source |
| Health Service Executive | 2024-Q2 | EUR 825,330 | payment_actual | source |
| Health Service Executive | 2024-Q1 | EUR 825,330 | payment_actual | source |
| Health Service Executive | 2024-Q2 | EUR 825,330 | payment_actual | source |
| Health Service Executive | 2024-Q2 | EUR 825,330 | payment_actual | source |
| Health Service Executive | 2024-Q1 | EUR 825,330 | payment_actual | source |
| Health Service Executive | 2024-Q1 | EUR 825,330 | payment_actual | source |
| Health Service Executive | 2024-Q4 | EUR 825,330 | payment_actual | source |
| Health Service Executive | 2024-Q4 | EUR 690,768 | payment_actual | source |
| Health Service Executive | 2024-Q4 | EUR 552,614 | payment_actual | source |
| Health Service Executive | 2024-Q4 | EUR 552,614 | payment_actual | source |
| Health Service Executive | 2024-Q4 | EUR 552,614 | payment_actual | source |
| Health Service Executive | 2024-Q2 | EUR 115,128 | payment_actual | source |
| Health Service Executive | 2023-Q3 | EUR 16,940,773 | payment_actual | source |
| Health Service Executive | 2023-Q4 | EUR 6,700,450 | payment_actual | source |
| Health Service Executive | 2023-Q4 | EUR 6,562,296 | payment_actual | source |
| Health Service Executive | 2023-Q4 | EUR 6,562,296 | payment_actual | source |
| Health Service Executive | 2023-Q4 | EUR 6,562,296 | payment_actual | source |
| Health Service Executive | 2023-Q3 | EUR 3,225,000 | payment_actual | source |
| Health Service Executive | 2023-Q1 | EUR 2,375,130 | payment_actual | source |
| Health Service Executive | 2023-Q1 | EUR 1,904,013 | payment_actual | source |
| Health Service Executive | 2023-Q4 | EUR 1,650,660 | payment_actual | source |
| Health Service Executive | 2023-Q4 | EUR 825,330 | payment_actual | source |
Awards
| Authority | Record | Value | Value kind | Single bid | Evidence |
|---|---|---|---|---|---|
| Health Service Executive (HSE) | Framework Agreement for Supply of Various Vaccine Products | EUR 0 | contract_award_value | no | source |
| Beaumont Hospital | Single Party Framework Agreement for the Supply if Infliximab Pharmaceutical Products | EUR 20,000,000 | framework_or_dps_ceiling | no | source |
| St James's Hospital | Coagulation Recombinant Factor IX | EUR 0 | contract_award_value | no | source |
| Beaumont Hospital | The Supply of Intravenous Rituximab Pharmaceutical Products | EUR 1,140,000 | framework_or_dps_ceiling | no | source |
| Health Service Executive (HSE) | Mini Competition for Voriconazole 200mg Injection for South East Hospital | EUR 53,097 | framework_or_dps_ceiling | no | source |
| Health Service Executive (HSE) | Supply and Delivery of Pneumococcal Conjugate (PCV) Vaccine | EUR 0 | framework_or_dps_ceiling | no | source |
Tenders
| Authority | Tender | Deadline | Estimate | Value kind | Evidence |
|---|---|---|---|---|---|
| No tender rows found for this supplier. | |||||
Lobbying Overlap
| Lobbying name | Lobbying returns | Award rows | Authorities | Safe award value |
|---|---|---|---|---|
| No supplier/lobbying overlap rows found for this supplier. | ||||